LICRLudwig Institute for Cancer Research
LICRLaboratory-Initiated CD4 (Cluster Difference 4) Reporting (AIDS surveillance methods)
Copyright 1988-2018, All rights reserved.
References in periodicals archive ?
These development candidates will be available to LICR for evaluation within the Cancer Vaccine Collaborative (CVC) worldwide clinical research network, a collaboration between the LICR and the leading cancer charity, the New York-based Cancer Research Institute.
The Ludwig Institute for Cancer Research (LICR) is the largest international academic institute dedicated to understanding and controlling cancer.
The scientific network that is LICR spans the globe.
Leveraging its worldwide network of investigators and the ability to sponsor and conduct its own clinical trials, LICR is actively engaged in translating its discoveries into applications for human benefit.
The antibody has been developed by a team of researchers at the Melbourne (Australia) Branch of the Ludwig Institute for Cancer Research (LICR).
Researchers at the LICR have identified a protein target that appears to play a key role in establishing and managing the destructive disease processes.